Press releases​

Lena Biosciences appoints Dr. Eckhard von Keutz to its Business Advisory Board and Science Advisory Board
​​

Company in the news​

Lena Biosciences featured in
​3D Cell Culture Market Report​​

Announcements and awards​

Landmark study with PerfusionPal featured in PLoS One:
Drug testing in fully humanized, 3D, perfused breast cancer model

Lena Biosciences receives over $1.8 M Phase II SBIR grant award to apply its screening platform to toxicity testing of chemicals implicated in neurodegenerative diseases

2022 Finalist
Mass Challenge US Early Stage Accelerator

Lena Biosciences receives $300 K  Phase I SBIR grant award to apply its screening platform to drug-induced liver injury

Finalist RESI Longevity Pitch Challenge
Therapeutics and Diagnostics, Sept. 2021

Lena Biosciences publishes Phase I drug metabolism results with PerfusionPal 

Interdigitated electrodes on SeedEZ scaffolds monitor cardiomyocyte growth

Lena Biosciences receives $252 K Phase I SBIR grant award to apply its screening platform to toxicity testing of agrochemicals

Lena Biosciences and SpeciCare, a tumor tissue bank, announce collaboration